NASH drives the accumulation of IgA+ immunosuppressive plasmocytes, a major source of PD-L1 and IL-10, which directly induce CD8+ T-cell exhaustion and impair antitumor surveillance (67). The gene discussed is CD79A; the disease is metabolic dysfunction-associated steatohepatitis.